David Bailey - Orthopediatrics Corp Executive Vice President

KIDS Stock  USD 31.20  0.57  1.86%   

President

Mr. David R. Bailey is Executive Vice President of the Company. Since 2009. Mr. Bailey joined our company in 2007 and has served as our Executive Vice President since 2009. Mr. Bailey also served as a member of our board of directors from 2007 to 2013. Prior to joining our company, Mr. Bailey worked as a sales representative and distributor for Smith Nephew plc since 2009.
Age 45
Tenure 15 years
Address 2850 Frontier Drive, Warsaw, IN, United States, 46582
Phone574 268 6379
Webhttps://www.orthopediatrics.com
Bailey earned a BS in Sales and Sales Management from Purdue University.

Orthopediatrics Corp Management Efficiency

The company has return on total asset (ROA) of (0.0372) % which means that it has lost $0.0372 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.0555) %, meaning that it created substantial loss on money invested by shareholders. Orthopediatrics Corp's management efficiency ratios could be used to measure how well Orthopediatrics Corp manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -0.08 in 2024. Return On Capital Employed is likely to drop to -0.07 in 2024. At this time, Orthopediatrics Corp's Total Assets are comparatively stable compared to the past year. Net Tangible Assets is likely to gain to about 255.9 M in 2024, whereas Total Current Assets are likely to drop slightly above 122.2 M in 2024.
The company currently holds 23.76 M in liabilities with Debt to Equity (D/E) ratio of 0.14, which may suggest the company is not taking enough advantage from borrowing. Orthopediatrics Corp has a current ratio of 4.66, suggesting that it is liquid enough and is able to pay its financial obligations when due. Debt can assist Orthopediatrics Corp until it has trouble settling it off, either with new capital or with free cash flow. So, Orthopediatrics Corp's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Orthopediatrics Corp sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Orthopediatrics to invest in growth at high rates of return. When we think about Orthopediatrics Corp's use of debt, we should always consider it together with cash and equity.
OrthoPediatrics Corp., a medical device company, designs, develops, and markets anatomically appropriate implants and devices for the treatment of children with orthopedic conditions in the United States and internationally. OrthoPediatrics Corp. was founded in 2006 and is headquartered in Warsaw, Indiana. OrthoPediatrics Corp operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 133 people. Orthopediatrics Corp (KIDS) is traded on NASDAQ Exchange in USA. It is located in 2850 Frontier Drive, Warsaw, IN, United States, 46582 and employs 247 people. Orthopediatrics Corp is listed under Health Care Equipment & Supplies category by Fama And French industry classification.

Management Performance

Orthopediatrics Corp Leadership Team

Elected by the shareholders, the Orthopediatrics Corp's board of directors comprises two types of representatives: Orthopediatrics Corp inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Orthopediatrics. The board's role is to monitor Orthopediatrics Corp's management team and ensure that shareholders' interests are well served. Orthopediatrics Corp's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Orthopediatrics Corp's outside directors are responsible for providing unbiased perspectives on the board's policies.
David Pelizzon, Independent Director
Marie Infante, Independent Director
Samuel Riccitelli, Independent Director
Bryan Hughes, Independent Director
Joel Batts, Senior Affairs
David Bailey, Executive Vice President
Mark Throdahl, President CEO, Director
Alan Kozlowski, Independent Director
Joseph Hauser, President Correction
Gregory Odle, Executive Vice President
Mark Karshner, Senior Sales
Peter Armstrong, Chief Medical Officer
Terry Schlotterback, Chairman of the Board
Bernie Berry, Independent Director
Stephen Burns, Independent Director
MBAMSHA CHE, President Technologies
Daniel Gerritzen, General Counsel and Vice President of Legal and Human Resources
Kevin Unger, Independent Director
Harald Ruf, Director
Fred Hite, CFO, Director
Peter Munson, Independent Director
Oscar Moralez, Independent Director
Tram Bui, IR Contact Officer

Orthopediatrics Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Orthopediatrics Corp a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Orthopediatrics Corp in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Orthopediatrics Corp's short interest history, or implied volatility extrapolated from Orthopediatrics Corp options trading.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Orthopediatrics Corp is a strong investment it is important to analyze Orthopediatrics Corp's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Orthopediatrics Corp's future performance. For an informed investment choice regarding Orthopediatrics Stock, refer to the following important reports:
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Orthopediatrics Corp. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in unemployment.
For more information on how to buy Orthopediatrics Stock please use our How to Invest in Orthopediatrics Corp guide.
Note that the Orthopediatrics Corp information on this page should be used as a complementary analysis to other Orthopediatrics Corp's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.

Complementary Tools for Orthopediatrics Stock analysis

When running Orthopediatrics Corp's price analysis, check to measure Orthopediatrics Corp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Orthopediatrics Corp is operating at the current time. Most of Orthopediatrics Corp's value examination focuses on studying past and present price action to predict the probability of Orthopediatrics Corp's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Orthopediatrics Corp's price. Additionally, you may evaluate how the addition of Orthopediatrics Corp to your portfolios can decrease your overall portfolio volatility.
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
AI Investment Finder
Use AI to screen and filter profitable investment opportunities
Commodity Directory
Find actively traded commodities issued by global exchanges
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Is Orthopediatrics Corp's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Orthopediatrics Corp. If investors know Orthopediatrics will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Orthopediatrics Corp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.92)
Revenue Per Share
6.559
Quarterly Revenue Growth
0.214
Return On Assets
(0.04)
Return On Equity
(0.06)
The market value of Orthopediatrics Corp is measured differently than its book value, which is the value of Orthopediatrics that is recorded on the company's balance sheet. Investors also form their own opinion of Orthopediatrics Corp's value that differs from its market value or its book value, called intrinsic value, which is Orthopediatrics Corp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Orthopediatrics Corp's market value can be influenced by many factors that don't directly affect Orthopediatrics Corp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Orthopediatrics Corp's value and its price as these two are different measures arrived at by different means. Investors typically determine if Orthopediatrics Corp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Orthopediatrics Corp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.